Lung cancer is the leading cause of cancer death worldwide, accounting for about 2. 4 million patients diagnosed and 1. 8 million deaths each year. 1 the two main types of lung cancer are non-small cell … On august 15, 2024, the food and drug administration approved durvalumab (imfinzi, astrazeneca) for resectable non-small cell lung cancer.